<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05049395</url>
  </required_header>
  <id_info>
    <org_study_id>RJ20210904</org_study_id>
    <nct_id>NCT05049395</nct_id>
  </id_info>
  <brief_title>HFNO Reducing the Incidence of Hypoxia for Hysteroscopy Sedated With Propofol</brief_title>
  <official_title>HFNO Reducing the Incidence of Hypoxia During the Procedure of Hysteroscopy Sedated With Propofol，a Randomized, Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>RenJi Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>RenJi Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To determine whether high-flow nasal cannula oxygen can reduce the incidence of hypoxia&#xD;
      during the procedure of sedated hysteroscopy.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 30, 2021</start_date>
  <completion_date type="Anticipated">September 2022</completion_date>
  <primary_completion_date type="Anticipated">September 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The incidence of hypoxia</measure>
    <time_frame>Patients will be followed for the duration of hospital stay, an expected average of 2 hours</time_frame>
    <description>75%≤SpO2&lt;90% and &lt;60S</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>The incidence of sub-clinical respiratory depression</measure>
    <time_frame>Patients will be followed for the duration of hospital stay, an expected average about 2 hours</time_frame>
    <description>90%≤SpO2&lt;95%</description>
  </secondary_outcome>
  <other_outcome>
    <measure>The incidence of severe hypoxia</measure>
    <time_frame>Patients will be followed for the duration of hospital stay, an expected average about 2 hours</time_frame>
    <description>SpO2 &lt; 75% or 75% ≤ SpO2 &lt;90% for &gt;= 60 s</description>
  </other_outcome>
  <other_outcome>
    <measure>The incidence of other adverse events</measure>
    <time_frame>Patients will be followed for the duration of hospital stay, an expected average about 2 hours</time_frame>
    <description>Other adverse events recorded by tools proposed by the World Society of Intravenous Anesthesia International Sedation Task Force</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">960</enrollment>
  <condition>Endometritis</condition>
  <condition>Tuberculous Endometritis</condition>
  <condition>Subseptate Uterus</condition>
  <condition>Endometrial Polyps</condition>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The patients are administered oxygen of 3L-6L/min until the end of the hysteroscopy operation.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>HFNO group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The patients are administered oxygen of 30L-60L/min until the end of the hysteroscopy operation.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>High Flow Nasal Cannula oxygen (HFNO)</intervention_name>
    <description>The AIRVO2 is set at 30L/min, FiO2 100%, and 37℃ before anesthesia induction，and then 60L/min until the end of the procedure of sedated hysteroscopy.</description>
    <arm_group_label>HFNO group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Regular oxygen</intervention_name>
    <description>The patients are administered oxygen of 3L-6L/min until the end of the hysteroscopy operation.</description>
    <arm_group_label>Control group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. 20 years old ≤ age ≤ 50 years old, female.&#xD;
&#xD;
          2. Undergoing hysteroscopy sedated with propofol for diagnosis or treatment.&#xD;
&#xD;
          3. Informed consent&#xD;
&#xD;
          4. BMI≤28kg/m2.&#xD;
&#xD;
          5. ASA physical status Ⅰ~ Ⅱ.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Epistaxis, nasal congestion and nasal mucosal damage.&#xD;
&#xD;
          2. Confirmed brain disease (cranial trauma, tumor, stroke, cognitive dysfunction etc.).&#xD;
&#xD;
          3. Confirmed severe heart disease (heart failure, angina pectoris, myocardial infarction,&#xD;
             arrhythmia, etc.).&#xD;
&#xD;
          4. Confirmed severe lung diseases (upper respiratory tract infection, asthma, bronchitis,&#xD;
             COPD, bullae, pulmonary embolism, pulmonary edema, lung cancer, etc.).&#xD;
&#xD;
          5. Pregnant women.&#xD;
&#xD;
          6. Acute and chronic hepatitis or liver cirrhosis with severe abnormal liver function.&#xD;
&#xD;
          7. Acute and chronic nephritis with severe abnormal renal function or renal failure.&#xD;
&#xD;
          8. Needing oxygen inhalation for underlying diseases.&#xD;
&#xD;
          9. Emergency surgery.&#xD;
&#xD;
         10. Combined with multiple trauma.&#xD;
&#xD;
         11. Allergic to soybean&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Su Diansan, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Anesthesiology</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Huang Yonglei, BA</last_name>
    <phone>86 13641637003</phone>
    <email>2367541746@qq.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Lu Qi, BA</last_name>
    <phone>86 21 68383364</phone>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Renji Hospital</name>
      <address>
        <city>Shanghai</city>
        <state>Shanghai</state>
        <zip>200127</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Diansan Su</last_name>
      <phone>+862168383702</phone>
      <email>diansansu@yahoo.com</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>July 13, 2021</study_first_submitted>
  <study_first_submitted_qc>September 8, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">September 20, 2021</study_first_posted>
  <last_update_submitted>September 29, 2021</last_update_submitted>
  <last_update_submitted_qc>September 29, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 1, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>HFNO</keyword>
  <keyword>Hysteroscopy</keyword>
  <keyword>Sedation</keyword>
  <keyword>Hypoxia</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Endometritis</mesh_term>
    <mesh_term>Hypoxia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

